11:51 AM EST - Microbix Biosystems Inc. : Announced the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are expected to total $25 million, with approximately $10 million being new business. Microbix Biosystems Inc.
shares T.MBX are trading up $0.02 at $0.28.
